Smith & Nephew plc SNN

Oil prices are holding above $100 a barrel as supply risks flare up again around the Strait of Hormuz, and that keeps pressure on inflation and interest rates. In this kind of market, solid British businesses with strong cash flows and cautious balance sheets can look overlooked as investors chase the latest story. This article walks through three such high quality UK stocks that our value screen flags as potentially mispriced. The three stocks profiled below are just a sample, as the full...

Smith & Nephew's (SNN) CartiHeal Agili-C Cartilage Repair Implant is now commercially available in E

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will take center stage at this week’s International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit in Porto, Portugal from October 8-10. Introduced by Smith+Nephew in the US during 2024, the CARTIHEAL Implant is rapidly transforming the cartilage repair landscape. Co

Smith+Nephew (LSE: SN, NYSE: SNN), compañía global de tecnología médica, anuncia hoy que su innovador implante de reparación de cartílago CARTIHEAL AGILI-C ya está disponible para su comercialización en Europa. El implante CARTIHEAL ocupará un lugar destacado en el Congreso de la Sociedad International de Regeneración de Cartílago & Preservación Articular (ICRS), que se celebrará en Oporto (Portugal) del 8 al 10 de octubre. Introducido por Smith+Nephew en Estados Unidos durante 2024, el implante

Smith+Nephew (LSE: SN, NYSE: SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l’innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata all’International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, che si terrà a Porto, in Portogallo, dall’8 al 10 ottobre. Introdotto negli Stati Uniti nel 2024, CARTIHEAL AGILI-C di Smith+Nephew nel panorama della riparazione della cartillagine. Composto da ara

Owens & Minor today named Carrie Childress executive vice president and chief marketing officer, effective immediately. In this newly created role, Childress becomes the first dedicated marketing executive in the company's more than 140-year history and will lead efforts to further strengthen the Owens & Minor brand and product portfolios.

Investing.com -- Goldman Sachs added Solaria, Straumann, Scout24 and IMCD to its European Conviction List for October, while removing Naturgy, Norsk Hydro and Smith & Nephew, the broker said in a note dated Thursday.

Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Sports Rehabilitation Equipment Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global sports rehabilitation equipment market is experiencing strong growth, driven by the rising incidence of sports injuries, expanding physiotherapy services and increasing awareness of rehabilitation therapies. The market is projected to grow from $4.39 billion in 2025 to $4.79 billion in 2026, representing a compound annual growth ra

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with LANDMARK Total Knee System, a next-generation knee replacement solution designed to replicate healthy knee anatomy and the knee’s natural motion and support a more personalized approach to total knee arthroplasty.As expectations for total knee arthroplasty continue to evolve, surgeons

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder and Elbow Surgery (ICSES) in Vancouver from September 22-25. Surgeons are invited to visit the Smith+Nephew booth during ICSES to learn more about the following technologies: TENDON SEAM Rotator Cuff Repair SystemRecently acquired by Smith+Nephew, the TENDON SEAM System is a unique

The latest analyst work on S.N. Nuclearelectrica centers on a revised price target of RON 49.75, up from RON 44.80. This sets a new reference point for how the stock is being valued. This change reflects a mix of optimism and caution in recent commentary, with research tying the new target to refreshed assumptions rather than a single event. As you read on, you will see how this evolving narrative might shape the way you track S.N. Nuclearelectrica from here. Stay updated as the Fair Value...

Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, GB / ACCESS Newswire / September 16, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the results of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 15, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the pricing of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.

Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 8, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announces today an offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.